new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Cancer Research Technology Limited
Cancer Research Technology Limited_20100128
  

Cancer Research Technology Limited patents

Recent patent applications related to Cancer Research Technology Limited. Cancer Research Technology Limited is listed as an Agent/Assignee. Note: Cancer Research Technology Limited may have other listings under different names/spellings. We're not affiliated with Cancer Research Technology Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cancer Research Technology Limited-related inventors




Date Cancer Research Technology Limited patents (updated weekly) - BOOKMARK this page
05/04/17Cd55-interaction partners and the uses thereof
04/20/17Pyridyl piperidines
04/20/17Protease inhibition
04/06/17Inhibiting gene expression with dsrna
03/23/171-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
03/09/17[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
02/23/17Antibodies and uses thereof
02/09/17Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor i
12/15/16N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as mps1 inhibitors
12/15/16Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as cdk inhibitors and their therapeutic use
12/08/16Therapeutic agents
12/08/161 -(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4h-pyrido[2, 3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as raf inhibitors for the treatment of cancer
10/20/165-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use
10/13/16Pharmacologically active compounds
10/13/16Process for the preparation of 8-(4-aminophenoxy)-4h-pyrido[2,3-b]pyrazin-3-one derivatives
10/13/16Method and system for predicting selective cancer drug targets
10/06/16Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
09/01/16Pyrazole derivatives as protein kinase modulators
08/04/16Inhibitor compounds
08/04/16Inhibitor compounds
08/04/16Biological fluid filtration assembly
06/23/16Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
06/09/16Anti-s100a4 antibody molecules and their uses
04/21/16Antibodies that bind to jagged 1
04/14/16Azaquinazoline inhibitors of atypical protein kinase c
03/10/16Modulators of the src-kinase activity for preventing or treating metastatic cancer
02/11/16Ccl22 and ccl17 cancer biomarkers
02/04/161-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
01/21/16Diagnostic and prognostic biomarkers for prostate cancer and other disorders
01/07/16Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
12/10/152-aminopyridine compounds
11/12/15Method for reprogramming somatic cells to pancreatic beta cells
10/15/15Materials and methods relating to modifying the binding of antibodies
10/01/15Azaquinazoline inhibitors of atypical protein kinase c
09/24/15Pharmaceutically active compounds
09/03/15[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
08/27/15Inhibitor compounds
08/13/155-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use
08/06/15Pharmacologically active compounds
07/23/15Anti-androgen peptides and uses thereof in cancer therapy
07/02/15Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
05/28/15Antibodies against hgf - receptor and uses
05/07/15Avß6 peptide ligands and their uses
05/07/155-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
03/05/15Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
02/12/15Inhibiting gene expression with dsrna
01/01/15Azaheterocyclic compounds
12/04/14Prognostic, screening and treatment methods and agents for treatment of metstasis and inflammation using t54 oncofoetal glycoprotein
11/06/14Immune modulation via c-type lectin
10/09/14Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
07/10/14Therapeutic agents
06/05/14[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
05/15/14N- (2 -aminophenyl) benzamide derivatives as histone deacetylase inhibitors
05/01/14Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
02/20/14Anti-tace antibody molecules and their uses
01/23/14Frmd4a antagonists and their uses
12/26/13Pyrrolopyridineamino derivatives as mps1 inhibitors
06/13/13Avß6 peptide ligands and their uses
03/21/13Insulin-like growth factor ii (igf-ii) binding factors
11/08/12Prognostic,. screening and treatment methods and agents for treatment of metastasis and inflammation using 5t4 oncofoetal glycoprotein
11/08/121-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
09/20/12Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
08/16/12Cancer
07/12/12Detection of dysplastic or neoplastic cells using anti-mcm6 antibodies
02/16/12Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
Patent Packs
09/01/11Immunogenic peptides and uses thereof
08/18/11Therapeutic oxy-phenyl-aryl compounds and their use
08/04/11Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/28/11Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
12/30/10Bicyclylaryl-aryl-amine compounds and their use
12/09/10Cancer
12/09/10Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
11/25/10[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
08/19/109h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h 1,3,6,9 tetraaza-fluorenes as chk1 kinase function inhibitors
07/01/10Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
06/10/10Detection of dysplastic or neoplastic cells using anti-mcm2 antibodies
05/27/10Pharmaceutical compounds
05/06/10Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
04/15/10Substituted piperidines having protein kinase inhibiting activity
04/15/10Compounds
Patent Packs
01/28/10Purine and deazapurine derivatives as pharmaceutical compounds
12/31/09New purine derivatives
12/10/09Insulin-like growth factor ii (igf-ii) binding factors
10/29/09Purine derivatives
10/08/09Pharmaceutical compounds
10/01/09Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/01/092-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use
07/30/09Imaging, diagnosis and treatment of disease
03/05/09Anti-cancer combinations
01/28/10Purine and deazapurine derivatives as pharmaceutical compounds







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cancer Research Technology Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cancer Research Technology Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';